Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 65326 - 65350 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Resveratrol	Investigational	MIR302D	442896	upregulated	resveratrol results in increased expression of MIR302D mRNA	4q25	A23973
Resveratrol	Investigational	MIR30A	407029	downregulated	resveratrol results in decreased expression of MIR30A mRNA	6q13	A23974
Resveratrol	Investigational	MIR30C1	407031	upregulated	resveratrol results in increased expression of MIR30C1 mRNA	1p34.2	A23974
Resveratrol	Investigational	MIR30D	407033	downregulated	resveratrol results in decreased expression of MIR30D mRNA	8q24.22	A23974
Resveratrol	Investigational	MIR30E	407034	downregulated	resveratrol results in decreased expression of MIR30E mRNA	1p34.2	A23974
Resveratrol	Investigational	MIR323A	442897	upregulated	resveratrol results in increased expression of MIR323A mRNA	14q32.31	A23974
Resveratrol	Investigational	MIR324	442898	upregulated	resveratrol results in increased expression of MIR324 mRNA	17p13.1	A23975
Resveratrol	Investigational	MIR328	442901	upregulated	resveratrol results in increased expression of MIR328 mRNA	16q22.1	A23975
Resveratrol	Investigational	MIR33A	407039	upregulated	resveratrol results in increased expression of MIR33A mRNA	22q13.2	A22517
Resveratrol	Investigational	MIR340	442908	upregulated	resveratrol results in increased expression of MIR340 mRNA	5q35.3	A23974
Resveratrol	Investigational	MIR342	442909	upregulated	resveratrol results in increased expression of MIR342 mRNA	14q32.2	A23973 A23975
Resveratrol	Investigational	MIR345	442910	upregulated	resveratrol results in increased expression of MIR345 mRNA	14q32.2	A23973
Resveratrol	Investigational	MIR34A	407040	downregulated	resveratrol results in decreased expression of MIR34A mRNA	1p36.22	A23977
Resveratrol	Investigational	MIR34A	407040	upregulated	resveratrol results in increased expression of MIR34A mRNA	1p36.22	A23973 A23976
Resveratrol	Investigational	MIR362	574030	downregulated	resveratrol results in decreased expression of MIR362 mRNA	Xp11.23	A23975
Resveratrol	Investigational	MIR362	574030	upregulated	resveratrol results in increased expression of MIR362 mRNA	Xp11.23	A23973
Resveratrol	Investigational	MIR363	574031	upregulated	resveratrol results in increased expression of MIR363 mRNA	Xq26.2	A23974 A23973
Resveratrol	Investigational	MIR375	494324	upregulated	resveratrol results in increased expression of MIR375 mRNA	2q35	A23973
Resveratrol	Investigational	MIR424	494336	downregulated	resveratrol results in decreased expression of MIR424 mRNA	Xq26.3	A23974
Resveratrol	Investigational	MIR4435-2HG	541471	downregulated	resveratrol results in decreased expression of MIR4435-2HG mRNA	2q13	A23852
Resveratrol	Investigational	MIR450B	100126302	downregulated	resveratrol results in decreased expression of MIR450B mRNA	Xq26.3	A23975
Resveratrol	Investigational	MIR491	574444	downregulated	resveratrol results in decreased expression of MIR491 mRNA	9p21.3	A23975
Resveratrol	Investigational	MIR491	574444	upregulated	resveratrol results in increased expression of MIR491 mRNA	9p21.3	A23975
Resveratrol	Investigational	MIR494	574452	upregulated	resveratrol results in increased expression of MIR494 mRNA	14q32.31	A23974 A23973 A23975
Resveratrol	Investigational	MIR497	574456	upregulated	resveratrol results in increased expression of MIR497 mRNA	17p13.1	A23974

Displaying entries 65326 - 65350 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability